Skip to content
10-Q

Quarterly Report

FUSE MEDICAL, INC. FZMD

0001437749-23-023606

← back to feed
Filed
Aug 14, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 10, 2023 73.9M sh
Shares Diluted Q2 2023 · Jun 30, 2023 78.03M sh
Shares Diluted Q2 2023 · Jun 30, 2023 78.03M sh
Shares Diluted Q2 2023 · Jun 30, 2022 70.32M sh
Capex Q2 2023 · Jun 30, 2023 $0
Capex restated Q2 2023 · Jun 30, 2022 $0
Operating Cash Flow Q2 2023 · Jun 30, 2023 $231.75K
Operating Cash Flow restated Q2 2023 · Jun 30, 2022 $247.91K
Cash And Equivalents Q2 2023 · Jun 30, 2023 $253.38K
Cash And Equivalents Q2 2023 · Dec 31, 2022 $147.85K
Stockholders Equity Q2 2023 · Jun 30, 2023 −$231.63K
Stockholders Equity Q2 2023 · Mar 31, 2023 −$539.22K
Stockholders Equity Q2 2023 · Dec 31, 2022 −$310.85K
Stockholders Equity restated Q2 2023 · Jun 30, 2022 −$4.21M
Stockholders Equity restated Q2 2023 · Mar 31, 2022 −$3.9M
Stockholders Equity Q2 2023 · Dec 31, 2021 −$3.43M
Current Liabilities Q2 2023 · Jun 30, 2023 $12.06M
Current Liabilities Q2 2023 · Dec 31, 2022 $12.39M
Total Liabilities Q2 2023 · Jun 30, 2023 $19.55M
Total Liabilities Q2 2023 · Dec 31, 2022 $20.07M
Current Assets Q2 2023 · Jun 30, 2023 $12.82M
Current Assets Q2 2023 · Dec 31, 2022 $13.77M
Total Assets Q2 2023 · Jun 30, 2023 $19.32M
Total Assets Q2 2023 · Dec 31, 2022 $19.76M
Eps Basic Q2 2023 · Jun 30, 2023 $0.00
Eps Basic Q2 2023 · Jun 30, 2023 $0.00
Eps Basic Q2 2023 · Jun 30, 2022 −$0.01
Sga Expense Q2 2023 · Jun 30, 2023 $1.62M
Sga Expense Q2 2023 · Jun 30, 2023 $3.32M
Sga Expense Q2 2023 · Jun 30, 2022 $3.13M
Net Income Q2 2023 · Jun 30, 2023 $307.59K
Net Income Q2 2023 · Jun 30, 2023 $79.23K
Net Income Q2 2023 · Mar 31, 2023 −$228.36K
Net Income restated Q2 2023 · Jun 30, 2022 −$322.94K
Net Income restated Q2 2023 · Jun 30, 2022 −$799.34K
Net Income restated Q2 2023 · Mar 31, 2022 −$476.4K
Operating Income Q2 2023 · Jun 30, 2023 $368.86K
Operating Income Q2 2023 · Jun 30, 2023 $203.28K
Operating Income restated Q2 2023 · Jun 30, 2022 −$719.82K
Gross Profit Q2 2023 · Jun 30, 2023 $3.47M
Gross Profit Q2 2023 · Jun 30, 2023 $6.28M
Gross Profit restated Q2 2023 · Jun 30, 2022 $5.45M
Cost Of Revenue Q2 2023 · Jun 30, 2023 $1.53M
Cost Of Revenue Q2 2023 · Jun 30, 2023 $2.7M
Cost Of Revenue restated Q2 2023 · Jun 30, 2022 $3.77M
Revenue Q2 2023 · Jun 30, 2023 $5M
Revenue Q2 2023 · Jun 30, 2023 $8.98M
Revenue Q2 2023 · Jun 30, 2022 $4.67M
Revenue Q2 2023 · Jun 30, 2022 $9.22M